These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Effect of digoxin upon intracellular potassium in man. Ericsson F; Carlmark B; Jogestrand T; Sundqvist K Scand J Clin Lab Invest; 1981 Sep; 41(5):457-63. PubMed ID: 7313528 [TBL] [Abstract][Full Text] [Related]
5. Human skeletal muscle digitalis glycoside receptors (Na,K-ATPase)--importance during digitalization. Schmidt TA; Holm-Nielsen P; Kjeldsen K Cardiovasc Drugs Ther; 1993 Feb; 7(1):175-81. PubMed ID: 8387326 [TBL] [Abstract][Full Text] [Related]
6. Effect of salbutamol on digoxin concentration in serum and skeletal muscle. Edner M; Jogestrand T Eur J Clin Pharmacol; 1989; 36(3):235-8. PubMed ID: 2744063 [TBL] [Abstract][Full Text] [Related]
7. Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity. Joreteg T; Jogestrand T Eur J Clin Pharmacol; 1983; 25(5):585-8. PubMed ID: 6662158 [TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle digoxin binding in patients with renal failure. Jogestrand T; Ericsson F Br J Clin Pharmacol; 1983 Jul; 16(1):109-11. PubMed ID: 6882618 [TBL] [Abstract][Full Text] [Related]
9. Quinidine-induced changes in serum and skeletal muscle digoxin concentration; evidence of saturable binding of digoxin to skeletal muscle. Jogestrand T; Schenck-Gustafsson K; Nordlander R; Dahlqvist R Eur J Clin Pharmacol; 1984; 27(5):571-5. PubMed ID: 6519162 [TBL] [Abstract][Full Text] [Related]
11. Effect of salbutamol on digoxin pharmacokinetics. Edner M; Jogestrand T; Dahlqvist R Eur J Clin Pharmacol; 1992; 42(2):197-201. PubMed ID: 1618253 [TBL] [Abstract][Full Text] [Related]
12. Cardiac effects of treatment with quinidine and digoxin, alone and in combination. Schenck-Gustafsson K; Jogestrand T; Brodin LA; Nordlander R; Dahlqvist R Am J Cardiol; 1983 Mar; 51(5):777-82. PubMed ID: 6829437 [TBL] [Abstract][Full Text] [Related]
13. Physical exercise and binding of digoxin to skeletal muscle--effect of muscle activation frequency. Joreteg T; Jogestrand T Eur J Clin Pharmacol; 1984; 27(5):567-70. PubMed ID: 6519161 [TBL] [Abstract][Full Text] [Related]
14. [Cardiac effects and glycoside concentrations in serum and urine after oral administration of beta-methy-digoxin to healthy individuals (author's transl)]. Haasis R; Larbig D; Klenk KO Klin Wochenschr; 1975 Jun; 53(11):529-33. PubMed ID: 1152344 [TBL] [Abstract][Full Text] [Related]
15. Beta-blockade and binding of digoxin to skeletal muscle. Joreteg T; Jogestrand T Clin Physiol; 1986 Apr; 6(2):183-90. PubMed ID: 3006980 [TBL] [Abstract][Full Text] [Related]
16. Steady-state concentrations and dosage of digoxin in relation to kidney function in hospitalized patients over 70 years of age. Algotsson A; Sanz E; Alván G J Intern Med; 1991 Mar; 229(3):247-51. PubMed ID: 2007843 [TBL] [Abstract][Full Text] [Related]
17. Skeletal muscle binding and renal excretion of digoxin in man. Schenck-Gustafsson K; Jogestrand T; Dahlqvist R Eur J Clin Pharmacol; 1987; 31(5):601-3. PubMed ID: 3830246 [TBL] [Abstract][Full Text] [Related]
18. Glucose uptake and binding of digoxin to skeletal muscle. Joreteg T; Efendic S; Jogestrand T Clin Physiol; 1986 Apr; 6(2):191-6. PubMed ID: 2869857 [TBL] [Abstract][Full Text] [Related]
19. Enhanced clearance of specifically bound digoxin from human myocardial and skeletal muscle samples by specific digoxin antibody fragments: subsequent complete digitalis glycoside receptor (Na,K-ATPase) quantification. Schmidt TA; Kjeldsen K J Cardiovasc Pharmacol; 1991 Apr; 17(4):670-7. PubMed ID: 1711637 [TBL] [Abstract][Full Text] [Related]
20. Myocardial and skeletal muscle concentrations of digoxin in patients on long-term therapy. Coltart J; Howard M; Chamberlain D Br Med J; 1972 May; 2(5809):318-9. PubMed ID: 4623290 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]